MDPITMulticentre Diltiazem Post Infarction Trial. A clinical trial in which patients age 25–75 were randomised post-acute myocardial infarction to receive either diltiazem, a calcium channel blocker, or a placebo.
MDPIT concluded that patients with pulmonary congestion or reduced ejection fraction did less well with diltiazem; those without these risk factors had a marginally significant reduction in cardiac events at one year of follow-up.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
MDPITCardiology A clinical trial–Multicenter Diltiazem Post Infarction Trial in which Pts were randomized 3-15 days post MI to receive diltiazem or a placebo. See Diltiazem, Myocardial infarction.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.